HIV Cure: Antiretroviral Therapy-Free Control of HIV Infection
April 7-10, 2025 | Southern Sun Elangeni & Maharani, Durban, NL, South Africa
Scientific Organizers:
Mike McCune, Thumbi Ndung'u, Sharon R. Lewin and Cissy Kityo
In Person
On Demand
April 7-10, 2025 | Southern Sun Elangeni & Maharani, Durban, NL, South Africa
Scientific Organizers:
Mike McCune, Thumbi Ndung'u, Sharon R. Lewin and Cissy Kityo
Available Formats:
In Person
On Demand
Supported by the Directors' Fund
Available Formats: = In Person = On Demand
Merchandise Options
Registration Options
Booking Function
Fundraising
Monday, April 7, 2025
Arrival and Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, April 8, 2025
Breakfast
7:00–8:00 AM
Welcome and Keynote Address
8:00–9:00 AM
Thumbi Ndung'u, University of KwaZulu-Natal
Combination Approaches for HIV Cure in Resource-Limited Settings
Combination Approaches for HIV Cure in Resource-Limited Settings
Biology of the Rebound Competent Reservoir I: The how, what, and why of the HIV reservoir
9:00–11:15 AM
Kavidha Reddy, Africa Health Research Institute
HIV-1 Clade C Reservoir Characteristics in South Africa
HIV-1 Clade C Reservoir Characteristics in South Africa
Ya-Chi Ho, Yale University
Mechanisms of Persistence
Mechanisms of Persistence
Sizun Jiang, Harvard
Reservoir Microenvironment
Reservoir Microenvironment
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
On Own for Lunch
11:15–5:00 PM
Poster Setup
11:15–1:00 PM
Poster Viewing
1:00–10:00 PM
Workshop 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Biology of the Rebound Competent Reservoir II: Host Factors that influence HIV persistence
5:00–7:00 PM
Melanie M. Ott, Gladstone Institute of Virology
Biology of Latency
Biology of Latency
Sharon R. Lewin, University of Melbourne
HIV-HBV Co-Infection and the Impact on HIV Persistence
HIV-HBV Co-Infection and the Impact on HIV Persistence
Caroline T. Tiemessen, National Institute for Communicable Diseases
Pediatrics
Pediatrics
Ujjwal Neogi, Karolinska Institutet
Metabolic Engineering of the Latent HIV Reservoir
Metabolic Engineering of the Latent HIV Reservoir
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Poster Session 1
7:30–10:00 PM
Wednesday, April 9, 2025
Breakfast
7:00–8:00 AM
Sizing Up the Reservoir Using Molecular and Visual Tools
8:00–11:00 AM
Jacob D. Estes, Oregon Health and Science University
Circulating Non-Viral Biomarkers of the Rebound Competent Reservoir
Circulating Non-Viral Biomarkers of the Rebound Competent Reservoir
Zaza M. Ndhlovu, Africa Health Research Institute
Biomarkers of the HIV Reservoir in Diverse Populations around the World12/07/23
Biomarkers of the HIV Reservoir in Diverse Populations around the World12/07/23
Lillian B. Cohn, Fred Hutchinson Cancer Center
Tissue Viral Reservoir and Cellular Immune Neighborhood Guided Biomarker Discovery
Tissue Viral Reservoir and Cellular Immune Neighborhood Guided Biomarker Discovery
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Poster Setup
11:00–1:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Therapeutic Approaches Leading to ART-Free Control of HIV I: What’s the magic ingredient?
5:00–7:00 PM
Sarah Fidler, Imperial College Faculty of Medicine
The Use of Broadly Neutralizing Antibodies to Confer HIV Viral Control off Antiretroviral Therapy
The Use of Broadly Neutralizing Antibodies to Confer HIV Viral Control off Antiretroviral Therapy
Thomas A. Rasmussen, Aarhus University Hospital
Inhibiting the Anti-Apoptotic Factor, BCL-2, as an Approach to Targeting HIV Persistence
Inhibiting the Anti-Apoptotic Factor, BCL-2, as an Approach to Targeting HIV Persistence
Rachel L. Rutishauser, University of California, San Francisco
Therapeutic vs. Preventative Vaccines – Overview
Therapeutic vs. Preventative Vaccines – Overview
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Poster Session 2
7:30–10:00 PM
Thursday, April 10, 2025
Breakfast
7:00–8:00 AM
Therapeutic Approaches Leading to ART-Free Control of HIV II: Might it all be in the genes?
8:00–11:00 AM
Cissy Kityo, Joint Clinical Research Center
CAR-T
CAR-T
Pamela Ting, Novartis Institutes for BioMedical Research
Talk Title to be Announced
Talk Title to be Announced
Andre Lieber, University of Washington
In vivo HSC Gene Therapy of HIV/AIDS and SCD with Helper-Dependent Adenovirus Vectors
In vivo HSC Gene Therapy of HIV/AIDS and SCD with Helper-Dependent Adenovirus Vectors
Julie Makani, Muhimbili University of Health and Allied Sciences
Translation of ex vivo SCD Rx to SSA
Translation of ex vivo SCD Rx to SSA
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Workshop 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Universal Access to Interventions that Lead to ART-Free Control of HIV: How are we going to make it happen?
5:00–6:45 PM
Steven G. Deeks, University of California, San Francisco
Combination Approaches Towards Eradication or Control of HIV
Combination Approaches Towards Eradication or Control of HIV
Izukanji Sikazwe, Centre for Infectious Disease Research in Zambia
HCAAP, a Public-Private Partnership to Bring Gene Therapies for HIV into Resource: Limited Parts of the World
HCAAP, a Public-Private Partnership to Bring Gene Therapies for HIV into Resource: Limited Parts of the World
Kenly Sikwese, AfroCAB Treatment Access Partnership
Talk Title to be Announced
Talk Title to be Announced
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Friday, April 11, 2025
Departure
8:00–8:00 AM
Subscribe for Updates